| Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy F Pastorino, C Brignole, D Di Paolo, B Nico, A Pezzolo, D Marimpietri, ... Cancer research 66 (20), 10073-10082, 2006 | 289 | 2006 |
| Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients I Casciano, K Mazzocco, L Boni, G Pagnan, B Banelli, G Allemanni, ... Cell Death & Differentiation 9 (3), 246-251, 2002 | 264 | 2002 |
| Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells M Pisano, G Pagnan, M Loi, ME Mura, MG Tilocca, G Palmieri, D Fabbri, ... Molecular cancer 6, 1-12, 2007 | 176 | 2007 |
| Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis C Brignole, D Marimpietri, F Pastorino, B Nico, D Di Paolo, M Cioni, ... Journal of the National Cancer Institute 98 (16), 1142-1157, 2006 | 157 | 2006 |
| Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD2-targeted immunoliposomes: antitumor effects G Pagnan, DD Stuart, F Pastorino, L Raffaghello, PG Montaldo, TM Allen, ... Journal of the National Cancer Institute 92 (3), 253-261, 2000 | 144 | 2000 |
| Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models F Pastorino, C Brignole, D Marimpietri, G Pagnan, A Morando, D Ribatti, ... Clinical cancer research 9 (12), 4595-4605, 2003 | 117 | 2003 |
| Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin F Pastorino, D Di Paolo, F Piccardi, B Nico, D Ribatti, A Daga, G Baio, ... Clinical Cancer Research 14 (22), 7320-7329, 2008 | 108 | 2008 |
| GD2‐mediated melanoma cell targeting and cytotoxicity of liposome‐entrapped fenretinide G Pagnan, PG Montaldo, F Pastorino, L Raffaghello, M Kirchmeier, ... International journal of cancer 81 (2), 268-274, 1999 | 103 | 1999 |
| Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region B Banelli, I Casciano, M Croce, AD Vinci, I Gelvi, G Pagnan, C Brignole, ... Nature medicine 8 (12), 1333-1335, 2002 | 102 | 2002 |
| Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma M Loi, S Marchiò, P Becherini, D Di Paolo, M Soster, F Curnis, C Brignole, ... Journal of controlled release 145 (1), 66-73, 2010 | 90 | 2010 |
| Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis D Marimpietri, C Brignole, B Nico, F Pastorino, A Pezzolo, F Piccardi, ... Clinical Cancer Research 13 (13), 3977-3988, 2007 | 88 | 2007 |
| Immune cell–mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs C Brignole, F Pastorino, D Marimpietri, G Pagnan, A Pistorio, TM Allen, ... Journal of the National Cancer Institute 96 (15), 1171-1180, 2004 | 87 | 2004 |
| Induction of apoptosis in human neuroblastoma cells by abrogation of integrin‐mediated cell adhesion C Rozzo, V Chiesa, G Caridi, G Pagnan, M Ponzoni International journal of cancer 70 (6), 688-698, 1997 | 87 | 1997 |
| Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma C Brignole, D Marimpietri, DD Paolo, P Perri, F Morandi, F Pastorino, ... Cancer research 70 (23), 9816-9826, 2010 | 86 | 2010 |
| Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK D Di Paolo, C Brignole, F Pastorino, R Carosio, A Zorzoli, M Rossi, M Loi, ... Molecular Therapy 19 (6), 1131-1140, 2011 | 78 | 2011 |
| Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma D Di Paolo, C Ambrogio, F Pastorino, C Brignole, C Martinengo, ... Molecular Therapy 19 (12), 2201-2212, 2011 | 76 | 2011 |
| Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells M Pisano, G Pagnan, MA Dettori, S Cossu, I Caffa, I Sassu, L Emionite, ... Molecular Cancer 9, 1-12, 2010 | 69 | 2010 |
| Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment C Brignole, G Pagnan, D Marimpietri, E Cosimo, TM Allen, M Ponzoni, ... Cancer letters 197 (1-2), 231-235, 2003 | 67 | 2003 |
| The use of the orthotopic model to validate antivascular therapies for cancer. M Loi, D Di Paolo, P Becherini, A Zorzoli, P Perri, R Carosio, M Cilli, ... International Journal of Developmental Biology 55, 2011 | 61 | 2011 |
| Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma G Zuccari, A Milelli, F Pastorino, M Loi, A Petretto, A Parise, C Marchetti, ... Journal of controlled release 211, 44-52, 2015 | 60 | 2015 |
